… develop many pharmaceutical Drugs in the United States, cancer treatments, all sorts of different kinds of treatments. The United States originally had a 17 year patent length for pharmaceutical drugs. We then had to increase that patent length in order to be in accordance with the WTO. And that meant that pharmaceutical companies held onto their patents longer. Drugs could not go generic. (30:40–30:48)
CLAIM
Asserts that the U.S. increased its patent length to comply with WTO agreements.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
